Metabolic rewiring during bone development underlies tRNA m7G-associated primordial dwarfism.

Bone biology Bone development Metabolism Translation

Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
10 Sep 2024
Historique:
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 10 9 2024
Statut: aheadofprint

Résumé

Translation of mRNA to protein is tightly regulated by tRNAs, which are subject to various chemical modifications that maintain the structure, stability and function. Deficiency of tRNA N7-methylguanosine (m7G) modification in patients causes a type of primordial dwarfism, but the underlying mechanism remains unknown. Here we report the loss of m7G rewires cellular metabolism, leading to the pathogenesis of primordial dwarfism. Conditional deletion of the catalytic enzyme Mettl1 or missense mutation of the scaffold protein Wdr4 severely impaired endochondral bone formation and bone mass accrual. Mechanistically, Mettl1 knockout decreased abundance of m7G-modified tRNAs and inhibited translation of mRNAs relating to cytoskeleton and Rho GTPase signaling. Meanwhile, Mettl1 knockout enhanced cellular energy metabolism despite of incompetent proliferation and osteogenic commitment. Further exploration revealed that impaired Rho GTPase signaling upregulated branched-chain amino acid transaminase 1 (BCAT1) level that rewired cell metabolism and restricted intracellular α-ketoglutarate (αKG). Supplementation of αKG ameliorated the skeletal defect of Mettl1-deficient mice. In addition to the selective translation of metabolism-related mRNAs, we further revealed that Mettl1 knockout globally regulated translation via integrated stress response (ISR) and mammalian target of rapamycin complex 1 (mTORC1) signaling. Restoring translation either by targeting ISR or mTORC1 aggravated bone defects of Mettl1-deficient mice. Overall, our study unveils a critical role of m7G tRNA modification in bone development by regulating cellular metabolism, and indicates that suspension of translation initiation as quality control mechanism in response to tRNA dysregulation.

Identifiants

pubmed: 39255038
pii: 177220
doi: 10.1172/JCI177220
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Qiwen Li (Q)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Shuang Jiang (S)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Kexin Lei (K)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Hui Han (H)

Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Yaqian Chen (Y)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Weimin Lin (W)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Qiuchan Xiong (Q)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Xingying Qi (X)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Xinyan Gan (X)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Rui Sheng (R)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Yuan Wang (Y)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Yarong Zhang (Y)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Jieyi Ma (J)

Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Tao Li (T)

West China-Washington Mitochondria and Metabolism Center and Department of , West China Hospital, Sichuan University, Chegndu, China.

Shuibin Lin (S)

Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Chenchen Zhou (C)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Demeng Chen (D)

Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Quan Yuan (Q)

State Key Laboratory of Oral Diseases & National Center for Stomatology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Classifications MeSH